Desloratadine
Brand Formulations & Prices
64 brands sorted by unit price
Delot
Desmark
Desotem
Aslor
Clarex
Delotad
Deslona
Desloratadine
Deslosil
Desolet
Destadin
Dora
Lara
Momento
Neocilor
Perilor
Prelora
Reelart
Sarinex
Unilor
Alertadin
Aloran
Deen
Desatrol
Destacin
Lorades
Orinex
Sedno
Delosia
Derat
Desatrol ODT
Desgud
Deslex
Deslorat
Desmin
Doralin
Neolor
Rhinex
Benlor
Desta
Destin
Des
Desodin
Deslor
Deslorin
Desofast
Desol
Delot
Desatrol
Desodin
Lorades
Momento
Deslor Kids
Deslorin
Dora
Delosia
Destin
Des
Deslona
Desotem
Desta
Neocilor
Unilor
Deslor
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesAlertadin is indicated for the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge & itching, congestion or stuffiness, as well as ocular itching, tearing and redness, itching of palate and coughing. Alertadin is also indicated for the relief of symptoms associated with chronic idiopathic urticaria such as the relief of itching and the size & number of hives.
Pediatric drops:
Child 6-11 months of age
: 2 ml drops once daily.
Child 1-2 years of age
: 2.5 ml drops once daily.
Syrup:
Child 6-11 months of age
: 2 ml once daily.
Child 1-5 years of age
: 2.5 ml once daily.
Child 6-11 years of age
: 5 ml once daily.
Adults & >12 years of age
: 10 ml once daily.
Tablet:
Adults and children 12 years of age and over
: 1 tablet daily
Desloratadine is contraindicated in patients having hypersensitivity to this medication or to any of its ingredients or Loratadine.
Less common side effects may include headache, nausea, fatigue, dizziness, pharyngitis, dyspepsia and myalgia.
In adult patients with liver or renal impairment: A starting dose of one 5 mg tablet every other day is recommended based on pharmacokinetic data. If the patient has medical or familial history of seizures.
Desloratadine, the major active metabolite of Loratadine, is a non-sedating; long acting tricyclic histamine antagonist with selective H1-receptor histamine antagonist activity. Desloratadine also inhibits histamine release from human mast cell.